CT-868

· Carmot Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CT-868, covering 2024-12-27 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus [Phase 2]